122
Views
0
CrossRef citations to date
0
Altmetric
Editorial

Positive Charge, Negative Effect: The Impact of Cationic Nanoparticles in The Brain

&
Pages 1441-1443 | Published online: 25 Sep 2014

References

  • Knudsen KB , NorthevedH, GjettingTet al. Biodistribution of rhodamine B fluorescence-labeled cationic nanoparticles in rats. J. Nanopart. Res.16, 2221 (2014). 
  • Knudsen KB , NorthevedH, EkPKet al. Differential toxicological response to positively and negatively charged nanoparticles in the rat brain. Nanotoxicology8, 764–774 (2014). 
  • Donaldson K , SeatonA. A short history of the toxicology of inhaled particles. Part. Fibre Toxicol.9, 13 (2012). 
  • Nemmar A , HoylaertsMF, HoetPHet al. Ultrafine particles affect experimental thrombosis in an in vivo hamster model. Am. J. Respir. Crit. Care Med.166, 998–1004 (2002). 
  • Silva VM , CorsonN, ElderA, OberdorsterG. The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicol. Sci.85, 983–989 (2005). 
  • M⊘ller P , MikkelsenL, VesterdalLKet al. Hazard identification of particulate matter on vasomotor dysfunction and progression of atherosclerosis. Crit. Rev. Toxicol.41, 339–368 (2011). 
  • Donaldson K , DuffinR, LangrishJPet al. Nanoparticles and the cardiovascular system: a critical review. Nanomed. (Lond.)8, 403–423 (2013). 
  • Shah V , TaratulaO, GarbuzenkoOBet al. Genotoxicity of different nanocarriers: possible modifications for the delivery of nucleic acids. Curr. Drug Discov. Technol.10, 8–15 (2013). 
  • Merhi M , DombuCY, BrientAet al. Study of serum interaction with a cationic nanoparticle: implications for in vitro endocytosis, cytotoxicity and genotoxicity. Int. J. Pharm.423, 37–44 (2012). 
  • Bonassi S , El-ZeinR, BolognesiC, FenechM. Micronuclei frequency in peripheral blood lymphocytes and cancer risk: evidence from human studies. Mutagenesis26, 93–100 (2011). 
  • Hamad-Schifferli K . How can we exploit the protein corona?   Nanomed. (Lond.)8, 1–3 (2013). 
  • Moghadam BY , HouWC, CorredorC, WesterhoffP, PosnerJD.  Role of nanoparticle surface functionality in the disruption of model cell membranes. Langmuir28, 16318–16326  (2012). 
  • Hirano A , UdaK, MaedaY, AkasakaT, ShirakiK.  One-dimensional protein-based nanoparticles induce lipid bilayer disruption: carbon nanotube conjugates and amyloid fibrils. Langmuir26, 17256–17259  (2010). 
  • Hong S , BielinskaAU, MeckeAet al. Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjugate Chem.15, 774–782 (2004). 
  • Mecke A , MajorosIJ, PatriAK, BakerJRJr, HollMM, OrrBG.  Lipid bilayer disruption by polycationic polymers: the roles of size and chemical functional group. Langmuir21, 10348–10354  (2005). 
  • M⊘ller P , JacobsenNR, FolkmannJKet al. Role of oxidative damage in toxicity of particulates. Free Radic. Res.44, 1–46 (2010). 
  • Scheule RK , St GeorgeJA, BagleyRGet al. Basis of pulmonary toxicity associated with cationic lipid-mediated gene transfer to the mammalian lung. Hum. Gene Ther.8, 689–707 (1997). 
  • Dokka S , ToledoD, ShiX, CastranovaV, RojanasakulY. Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes. Pharm. Res.17, 521–525 (2000). 
  • Xia T , KovochichM, BrantJet al. Comparison of the abilities of ambient and manufactured nanoparticles to induce cellular toxicity according to an oxidative stress paradigm. Nano. Lett.6, 1794–1807 (2006). 
  • Bexiga MG , VarelaJA, WangFet al. Cationic nanoparticles induce caspase 3-, 7- and 9-mediated cytotoxicity in a human astrocytoma cell line. Nanotoxicology5, 557–567 (2011). 

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.